NCT03336242: Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence Seizures
- State
- Stopped early
- Phase
- Phase 2
- People
- 20 taking part
- Started
- 29 Dec 2017
- Primary completion
- 15 May 2019
- Arms
- Cohort 1: Cannabidiol Oral Solution 20 mg/kg/day, Cohort 2: Cannabidiol Oral Solution 30 mg/kg/day, Cohort 3: Cannabidiol Oral Solution 10 mg/kg/day
- Results
- Posted on the registry
- 8 Nov 2017: Trial registered
- 29 Dec 2017: Trial started
- 29 May 2019: Trial terminated
- 21 Jul 2023: Trial results posted